Priti Lal, MD

Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Simon F. Lacey, Andrew J. Rech, Megan M. Davis, Wei-Ting Hwang, Priti Lal, Erica L. Carpenter, Shannon L. Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie A. Sebro, Michael D. Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, Sarah E. Church, Tyler D. Hether, Jun Xu, Mercy Gohil, Thomas H. Buckingham, Stephanie S. Yee, Vanessa E. Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney Gladney, Christopher L. Nobles, Hayley E. Raymond, Prostate Cancer Cellular Therapy Program Investigators, Elizabeth O. Hexner, Donald L. Siegel, Frederic D. Bushman, Carl H. June, Joseph A. Fraietta & Naomi B. Haas PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial , Nature Medicine, 4(28): 2022,724-734

Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal Priti, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, Schaeffer EM Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer , J Clin Oncol, 33(25): 2015,2789-96

Vaughn DJ, Hwang WT, Lal Priti, Rosen MA, Gallagher M, O'Dwyer PJ Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors , Cancer, 121(9): 2015,1463-8

Garg R, Blando JM, Perez CJ, Lal Priti, Feldman MD, Smyth EM, Ricciotti E, Grosser T, Benavides F, Kazanietz MG COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer , Oncogene, 37(34): 2018,4735-4749

Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Fu P, Yamoah K, Khani F, Robinson BD, Rebbeck TR, Feldman M, Lal Priti, Madabhushi A Computationally derived image signature of stromal morphology is prognostic of prostate cancer recurrence following prostatectomy in African American patients , Clin Cancer Res, 26(8): 2020,1915-1923

Rasool RU, Natesan R, Deng Q, Aras S, Lal Priti, Sander Effron S, Mitchell-Velasquez E, Posimo JM, Carskadon S, Baca SC, Pomerantz MM, Siddiqui J, Schwartz LE, Lee DJ, Palanisamy N, Narla G, Den RB, Freedman ML, Brady DC, Asangani IA CDK7 inhibition suppresses Castration- Resistant Prostate Cancer through MED1 inactivaion , Cancer Discov, 9(11): 2019,1538-1555

Arriola AGP, Farahani SJ, Bhargava HK, Guzzo TJ, Brooks JSJ, Lal Priti PDL-1 Expression reveals significant association with squamous differentiation in Upper Tract Urothelial Carcinoma , Am J Clin Pathol, 151(6): 2019 ,561-573

Sadigh S, Farahani SJ, Shah A, Vaughn D, Lal Priti Differences in PD-L1 Expressing Macrophages and Immune Micro-environment in Testicular Germ Cell Tumors , Am J Clin Pathol, 153(3): 2020,387-395

Vivek Narayan, Whitney Gladney, Gabriela Plesa, Neha Vapiwala, Erica Carpenter, Shannon L. Maude, Priti Lal, Simon F. Lacey, Jan Joseph Melenhorst, Ronnie Sebro, Michael Farwell, Wei-Ting Hwang, Michael Moniak, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, Christina Marie Coughlin, Carl H. June, Naomi B. Haas A Phase 1 Clinical Trial of PSMA-directed/TGFβ-insensitive CAR-T cells in Metastatic Castration-Resistant Prostate Cancer , Am Soc of Clin Onc 2020. J of Clin Onc : 2020

Facciabene A, Peng X, Ian SH, Barchetti A, Balint K, Wang LP, Gilks CB, Lal Priti, Zhang L, Coukos G Tumor Hypoxia Recruits Regulatory T Cells via the CCL28 Chemokine to Promote Immune Tolerance and Angiogenesis , Nature, 475(7355): 2011,226-230